Assembly Biosciences Valuation
| ASMB Stock | USD 14.93 0.28 1.91% |
At this time, the firm appears to be overvalued. Assembly Biosciences shows a prevailing Real Value of $9.68 per share. The current price of the firm is $14.93. Our model approximates the value of Assembly Biosciences from analyzing the firm fundamentals such as Operating Margin of (1.75) %, shares outstanding of 5.48 M, and Return On Equity of -0.99 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Assembly Biosciences' valuation include:
Price Book 1.9545 | Enterprise Value -47.6 M | Enterprise Value Ebitda 0.7412 | Price Sales 11.2135 | Enterprise Value Revenue 5.8492 |
Overvalued
Today
Please note that Assembly Biosciences' price fluctuation is slightly risky at this time. Calculation of the real value of Assembly Biosciences is based on 3 months time horizon. Increasing Assembly Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Assembly Biosciences is useful when determining the fair value of the Assembly stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Assembly Biosciences. Since Assembly Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Assembly Stock. However, Assembly Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14.93 | Real 9.68 | Target 3.0 | Hype 15.24 |
The real value of Assembly Stock, also known as its intrinsic value, is the underlying worth of Assembly Biosciences Company, which is reflected in its stock price. It is based on Assembly Biosciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Assembly Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Assembly Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Assembly Biosciences helps investors to forecast how Assembly stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Assembly Biosciences more accurately as focusing exclusively on Assembly Biosciences' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Assembly Biosciences' intrinsic value based on its ongoing forecasts of Assembly Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Assembly Biosciences' closest peers. When choosing an evaluation method for Assembly Biosciences, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Assembly Biosciences Investments |
|
Assembly Valuation Trend
Knowing Assembly Biosciences' actual value is paramount for traders to make sound investment determinations. Assembly Biosciences' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Assembly Biosciences' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Assembly Biosciences' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Assembly Market Cap
Assembly Biosciences is rated fourth in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 1.2 Billion. Assembly Biosciences holds roughly 80.32 Million in market capitalization claiming about 7% of equities under Health Care industry.Assembly Biosciences Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Assembly Biosciences's current stock value. Our valuation model uses many indicators to compare Assembly Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Assembly Biosciences competition to find correlations between indicators driving Assembly Biosciences's intrinsic value. More Info.Assembly Biosciences is rated fifth in price to earning category among related companies. It is rated second in price to book category among related companies . As of April 16, 2024, Price To Book Ratio is expected to decline to 1.04. Comparative valuation analysis is a catch-all model that can be used if you cannot value Assembly Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Assembly Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Assembly Biosciences' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Assembly Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Assembly Biosciences and how it compares across the competition.
About Assembly Biosciences Valuation
The stock valuation mechanism determines the current worth of Assembly Biosciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Assembly Biosciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Assembly Biosciences based exclusively on its fundamental and basic technical indicators. By analyzing Assembly Biosciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Assembly Biosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Assembly Biosciences. We calculate exposure to Assembly Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Assembly Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 6.7 M | 7 M | |
| Pretax Profit Margin | (9.82) | (10.32) | |
| Operating Profit Margin | (10.38) | (10.90) | |
| Net Loss | (9.83) | (10.32) | |
| Gross Profit Margin | 1.08 | 1.06 |
8 Steps to conduct Assembly Biosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Assembly Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Assembly Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Assembly Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Assembly Biosciences' revenue streams: Identify Assembly Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Assembly Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Assembly Biosciences' growth potential: Evaluate Assembly Biosciences' management, business model, and growth potential.
- Determine Assembly Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Assembly Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Assembly Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Assembly Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.6 M |
Assembly Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Assembly Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Assembly we look at many different elements of the entity such as Assembly's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Assembly Biosciences' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Assembly Biosciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Assembly Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Assembly Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Assembly Biosciences' worth.When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Assembly Stock analysis
When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Assembly Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.38) | Revenue Per Share 1.565 | Quarterly Revenue Growth (1.00) | Return On Assets (0.34) | Return On Equity (0.99) |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.